SAnews.gov.za: South African HIV/AIDS trial scoops USAID award
“The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 Tenofovir gel trial was … announced as the winner of the United States Agency for International Development (USAID) Science and Technology Pioneers Prize. … The CAPRISA 004 Tenofovir gel trial, conducted in KwaZulu-Natal, was funded by USAID and the South African Department of Science and Technology, and conducted by a group of South African and U.S. researchers. It provided proof of concept that an antiretroviral gel used before and after sex can protect women against HIV…” (1/29).